CRXL, DSM announce JV to produce ‘biobetter’ FoB’s using PER.C6 technology: http://finance.yahoo.com/news/DSM-and-Crucell-Announce-iw-3044120024.html?x=0&.v=1 Jim Mullen, ex-CEO of BIIB, is Chairman of the new JV. Sounds like a better job than running BIIB in the post-Gilenya era :- )